Stepping up research and innovation to beat TB
In a year dedicated to progressing the fight against tuberculosis — with the upcoming United Nations High-level Political Meeting — the evidence casts a bleak outlook. But there's hope.
Read more
In a year dedicated to progressing the fight against tuberculosis — with the upcoming United Nations High-level Political Meeting — the evidence casts a bleak outlook. But there's hope.
Read more Discover how the innovative pharmaceutical industry works with partners to advance the SDGs
Read more
On 22 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 10: WHO Pathogen Access and Benefit Sharing System, with the Pandemic Influenza Preparedness Framework as an example” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read moreOn 20 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 7: Access to technology: promoting sustainable and equitably distributed production sustainable and equitably distributed production and transfer of technology and know-how” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read moreOn 20 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 7: Access to technology: promoting sustainable and equitably distributed production and transfer of technology and know-how” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read moreOn 17 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 18: One Health and the Quadripartite” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read moreOn 17 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 6: Predictable global supply chain and logistics network” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read moreOn 17 March, IFPMA delivered a statement at the 52 Regular Session of the Human Rights Council (HRC) for the Interactive Dialogue with the Human Rights Commissioner on the report on Access to COVID-19 Vaccines.
Read moreThis joint position paper covers the perspective from industry on the proposed fee system for regional joint assessment procedures in Africa.
Read more
On 28 February, IFPMA delivered a statement at the fourth meeting of the Intergovernmental Negotiating Body (INB) for a WHO instrument on pandemic prevention, preparedness and response held from 27 February - 3 March 2023.
Read moreIn the wake of the devastating earthquakes in Türkiye and Syria, a number of our member companies are working to ensure supply chains function and get vital medicines to existing patients, as well as medical supplies and financial donations to those affected by the earthquakes. Industry will also continue to work with partners and authorities to provide further support where possible.
Read moreOn 21 February, IFPMA delivered a statement at the second meeting of the Working Group on amendments to the International Health Regulations (2005) (WGIHR) held from 20-24 February 2023.
Read more